Intradermal acupuncture and self-rehabilitation for severe Bell's Palsy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effects of intradermal acupuncture (IA) and a guided self-rehabilitation management program (GRMP) on patients with severe Bell's Palsy. Participants will be randomly assigned to one of four groups: active IA combined with GRMP, active IA with health education, sham IA with GRMP, or sham IA with health education. The interventions will continue until participants achieve complete recovery or complete the 24-week follow-up period, with assessments at regular intervals. The goal is to determine the efficacy of these treatments in improving recovery outcomes for Bell's Palsy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients diagnosed with Bell's palsy according to "Clinical Practice Guideline: Bell's Palsy" published by AAO-HNS in 2013;
* First onset of Bell's palsy with only one side affected;
* On the 10th day after the onset of palsy, HBGS score ranging from grade IV to VI;
* According to the latest Chinese Guidelines for Bell's Palsy, within 72 hours of symptom onset for Bell's Palsy, oraling prednisolone 30mg qd for 5 days, followed by tapering to zero in decrements of 5 mg per day;
* Adults aged 18 years of age or older (no limitation on gender).

Exclusion Criteria:

* Facial paralysis caused by acoustic neuroma, otitis media, mastoiditis, mumps, Hunter's syndrome, cranial base meningitis, intracranial metastasis of cancer or multiple sclerosis;
* Fear of intradermal acupuncture;
* allergy to adhesive tape;
* Severe allergic diseases, significant skin lesions, tumors, and severe or unstable internal diseases involving the cardiovascular, respiratory, endocrine, digestive, or hematological system;
* Cognitive impairment, mental illness, contagious disease, pregnant and lactating;
* Previously treated withintradermal acupuncture or participating in other clinical trial within 3 months.

Where it's running

• Zhangjiagang First People's Hospital
  Suzhou, Jiangsu, China Recruiting

Study contacts

• Principal investigator: yang Jiang, master — Zhangjiagang First People's Hospital
• Study coordinator: yang Jiang, master
• Email: 17768069362@163.com
• Phone: 17768069362

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Exploring the link between facial paralysis and homocysteine levels

  This study looks at whether higher levels of a substance in the blood called homocysteine are linked to Bell's palsy in adults who suddenly experience facial weakness or paralysis.

  Recruiting at 2 sites Afyonkarahisar Health Sciences University · Afyonkarahisar and 2 other locations · NCT06742580

• Laser acupuncture treatment for Bell's palsy

  This study is testing if laser acupuncture can help people with Bell's palsy feel better compared to standard treatments and a fake treatment.

  Recruiting Beijing Tongren Hospital · Beijing, Beijing Municipality · NCT06732622

• Comparing Prednisolone and Cerebrolysin for treating Bell's Palsy

  This study is testing whether Prednisolone or Cerebrolysin works better to help people with Bell's Palsy recover and avoid complications.

  Recruiting Phase 1/2 October 6 University · Giza · NCT05821075

• Combined neural mobilization with proprioceptive therapy for Bell’s palsy facial symmetry

  A randomized trial tests whether adding neural mobilization to proprioceptive neuromuscular facilitation helps improve facial symmetry in people with Bell’s palsy.

  Recruiting Foundation University Islamabad · Islamabad · NCT07758543

• Intradermal acupuncture for ocular surface problems after intractable facial paralysis

  This study will test whether tiny needles placed just under the skin can improve dry eye and other ocular surface symptoms in adults with persistent peripheral facial paralysis.

  Recruiting The First Affiliated Hospital of Zhejiang Chinese Medical University · Hangzhou, Zhejiang · NCT07537426

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.